• Explore /
  • Poster
  • / A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS).

A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS).

Abstract Poster

Authors

Alona Zer

Alona Zer

Princess Margaret Cancer Centre, Toronto, ON, Canada

Alona Zer , Oded Icht , Lilach Joseph , Dana Avram , Oded Jacobi , Eyal Fenig , Noga Kurman , Idit Peretz , Sivan Shamai , Ofer Merimsky , Eitan Ben-Ami , Roni Shapira , Anna Ewa Schwarzbach , Hanna Bernstine , Rony Weitzen , Olga Vornicova , Gil Bar-Sela , Salomon M. Stemmer , Michal Lotem

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03219671

Citation

J Clin Oncol 38: 2020 (suppl; abstr 11518)

DOI

10.1200/JCO.2020.38.15_suppl.11518

Abstract #

11518

Poster Bd #

406

Abstract Disclosures

Similar Posters

First Author: Alona Zer

First Author: Katie Streicher

First Author: Jacob J. Adashek

First Author: Vanessa Anne Eulo